CYTENA
Fernando Aprile García has a diverse work experience spanning various roles and industries.
Fernando most recently worked at CYTENA, where they held multiple positions. Fernando started as a Senior Application Scientist in September 2021 and then took on the role of Chapter Lead Cell Line Development Applications from April 2022 to December 2022. Currently, they hold the position of Head of Applications at CYTENA.
Prior to their time at CYTENA, Fernando worked at the Max-Planck Institute of Immunobiology and Epigenetics as a Postdoctoral Researcher from June 2014 to September 2021.
Fernando also gained experience as a Visiting PhD Student at the Max-Planck-Institut für Psychiatrie in January 2014 and at the Max Planck Institute of Experimental Medicine in January 2010.
As a Ph.D. Student in Molecular Biology at IBioBA - CONICET - Partner Institute of the Max Planck Society, Fernando conducted research from April 2009 to March 2014.
In addition, they served as a Graduate Teaching Assistant at Facultad de Ciencias Exactas y Naturales, UBA from March 2009 to March 2014, and as an Undergraduate Teaching Assistant from March 2007 to February 2009.
Fernando Aprile García also pursued a Master's degree at IFIBYNE - CONICET from May 2007 to March 2009.
Fernando Aprile García pursued their education in the field of Molecular Biology. Fernando earned their Master of Science (MS) degree from the University of Buenos Aires from 2004 to 2009. Subsequently, they went on to complete a Doctor of Philosophy (PhD) degree in Molecular Biology from the same university, studying from 2009 to 2014.
CYTENA
cytena GmbH has developed a device called cy-Clone to separate single cells. Single cells are required for the development of state-of-the-art drugs, so-called biologicals as well as for the genetic analysis of single cells for cancer and stem cell research. The cy-Clone is supported by an automated imaging process to encapsulate cells indroplets, which are delivered to any type of substrate. Thanks to this particularly gentle delivery method, the cells are able to survive post printing and can either be analyzed thereafter or grown into clonal colonies. To determine clonality, multiple images are recorded during the process. Cross-contamination is avoided by the use of disposable parts.